Galecto, Inc. (NASDAQ:GLTO – Get Free Report) was the target of a significant drop in short interest in the month of May. As of May 31st, there was short interest totalling 9,300 shares, a drop of 80.4% from the May 15th total of 47,400 shares. Approximately 0.1% of the company’s stock are short sold. Based […]
Galecto (NASDAQ:GLTO – Get Free Report) and Achaogen (OTCMKTS:AKAOQ – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, risk, valuation, dividends, earnings, profitability and institutional ownership. Volatility and Risk Galecto has a beta of 1.26, […]
/PRNewswire/ The global lung cancer therapeutics market size is estimated to grow by USD 10.52 billion from 2024-2028, according to Technavio. The market is.
Galecto Announces First Patient Dosed In An Investigator-Initiated Phase 2 Trial Of GB1211 In Combination With Pembrolizumab menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
Research Analysts Offer Predictions for Galecto, Inc s FY2028 Earnings (NASDAQ:GLTO) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.